US Stock MarketDetailed Quotes

BMY Bristol-Myers Squibb

Watchlist
  • 58.210
  • +0.330+0.57%
Close Feb 25 16:00 ET
  • 58.262
  • +0.052+0.09%
Post 20:01 ET
118.13BMarket Cap-13.20P/E (TTM)

About Bristol-Myers Squibb Company

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Company Profile

SymbolBMY
Company NameBristol-Myers Squibb
Listing DateJun 1, 1969
Issue Price40.50
Founded1933
CEODr. Christopher S. Boerner, PhD
MarketNYSE
Employees34100
Fiscal Year Ends12-31
AddressRoute 206 & Province Line Road
CityPrinceton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08543
Phone1-609-252-4621
Websitehttp://www.bms.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Christopher S. Boerner, PhD
  • Chairman of the Board and Chief Executive Officer
  • 8.46M
  • Gregory Scott Meyers
  • Executive Vice President, Chief Digital Officer and Chief Technology Officer
  • --
  • Adam Lenkowsky
  • Executive Vice President and Chief Commercialization Officer
  • --
  • Dr. Robert M. Plenge, M.D.,PhD
  • Executive Vice President, Chief Research Officer and Head of Research
  • --
  • David V. Elkins
  • Executive Vice President and Chief Financial Officer
  • 7.17M
  • Amanda Ahn Poole
  • Executive Vice President and Chief People Officer
  • --
  • Dr. Samit Hirawat, M.D.
  • Executive Vice President, Chief Medical Officer and Head of Development
  • 6.23M
  • Phil Holzer
  • Senior Vice President, Principal Accounting Officer and Controller
  • --
  • Cari Gallman
  • Executive Vice President, Corporate Affairs
  • --
  • Karin Shanahan
  • Executive Vice President, Global Product Development and Supply
  • --
  • Sandra Leung
  • Executive Vice President and General Counsel
  • 5.92M
  • Benjamin J. Hickey, M.B.A.
  • President, RayzeBio Organization
  • --
  • Lynelle Hoch
  • President, Cell Therapy Organization
  • --
  • Paula A. Price
  • Independent Director
  • 365.00K
  • Dr. Deepak L. Bhatt, M.D.,M.P.H.
  • Independent Director
  • 329.97K
  • Dr. Karen H. Vousden, PhD
  • Independent Director
  • 344.74K
  • Derica W. Rice
  • Independent Director
  • 375.00K
  • Theodore R. Samuels
  • Lead Independent Director
  • 425.00K
  • Dr. Julia A. Haller, M.D.
  • Independent Director
  • 371.68K
  • Peter J. Arduini
  • Independent Director
  • 359.68K
  • Dr. Manuel Hidalgo Medina, M.D.,PhD
  • Independent Director
  • 335.00K
  • Phyllis R. Yale
  • Independent Director
  • 365.00K
  • Michael R. McMullen
  • Independent Director
  • --
Trending Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
Hutchmed (China)
HCM
+2.21%
Enerpac Tool
EPAC
+2.10%
Ermenegildo Zegna NV
ZGN
+1.63%
Lantheus
LNTH
+1.39%
eBay
EBAY
+1.34%

Unlock the Full List

Investment Theme Cancer Research
Cancer Research
Intraday+0.34%